This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana is a health benefits company that offers coordinated health insurance coverage and related services through a variety of plans for retirees, employer groups, and government-sponsored programs, such as Medicare Advantage and Medicaid. Humana serves nearly 17 million medical members and 5 million specialty and dental members. The company's CenterWell health services segment offers PBM services, home care services, and primary care services. HUM shares are a component of the S&P 500. Humana has a strong position in the Medicare Advantage (MA) market and growth opportunities in its healthcare services business. The MA market is expanding rapidly as aging Americans seek secure medical and insurance benefits during retirement. The U.S. Census Bureau has estimated that the number of U.S. residents over 65 will double over the next four decades, with one in five residents over the age of 65 by 2030.

The stock market finally saw a little reversion to the mean on Friday, March 8, as the most-loved stock and industry was whacked. Nvidia (NVDA) fell 5.5%, its worst day since May 2023. This followed huge advances of 95% since January 3 and 130% since October 2023. Over six days (ending March 7), the shares rose more than 19%. At Friday's intraday high, NVDA hit $974 and then was slammed down to $865 by 1:35 pm.